Prelude Therapeutics Q1 2026 Earnings Significant EPS Beat Amid No Revenue Autohome Q4 2025 Earnings EPS Misses Estimates by a Narrow Margin Stock Dips UUU Q4 2024 Earnings Loss per Share of 021 Amid Mixed Reporting ASP Isotopes Q4 2025 Earnings PreRevenue Developer Reports WiderthanExpected Loss Yet Shares Rally 735 Stantec Inc STN Q1 2026 Earnings EPS Beat Driven by Robust Project Backlog and Margin Improvement V Q1 2026 Earnings EPS Surges Past Estimates Revenue Data Pending